$20.89
2.20%
Nasdaq, Dec 27, 09:31 pm CET
ISIN
US98978N2009
Symbol
ZIVO
Sector
Industry

Zivo Bioscience Inc Target price 2024 - Analyst rating & recommendation

Zivo Bioscience Inc Classifications & Recommendation:

Buy
100%

Zivo Bioscience Inc Price Target

Target Price $12.00
Price $20.89
Deviation
Number of Estimates 1
1 Analyst has issued a Zivo Bioscience Inc price target 2025. The average Zivo Bioscience Inc target price is $12.00. This is lower than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Zivo Bioscience Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Zivo Bioscience Inc stock has an average upside potential 2025 of . Most analysts recommend the Zivo Bioscience Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.03 0.14
373.33%
EBITDA Margin -24,200.00% -9,763.38%
59.66%
Net Margin -53,513.33% -11,010.70%
79.42%

1 Analyst has issued a sales forecast Zivo Bioscience Inc 2024 . The average Zivo Bioscience Inc sales estimate is

$142k
Unlock
. This is
77.50% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$142k 77.50%
Unlock
, the lowest is
$142k 77.50%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $30.0k
2024
$142k 373.33%
Unlock
2025
$1.4m 890.85%
Unlock
2026
$2.0m 44.99%
Unlock

1 Analyst has issued an EBITDA forecast Zivo Bioscience Inc 2024 . The average Zivo Bioscience Inc EBITDA estimate is

$-13.9m
Unlock
. This is
1.49% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-13.9m 1.49%
Unlock
, the lowest is
$-13.9m 1.49%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-7.3m 16.07%
2024
$-13.9m 90.96%
Unlock
2025
$-6.5m 53.00%
Unlock
2026
$-6.1m 6.06%
Unlock

EBITDA Margin

2023 -24,200.00%
2024
-9,763.38% 59.66%
Unlock
2025
-463.11% 95.26%
Unlock
2026
-300.05% 35.21%
Unlock

1 Analyst has issued a net profit forecast Zivo Bioscience Inc 2024 . The average Zivo Bioscience Inc net profit estimate is

$-15.6m
Unlock
. This is
7.98% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-15.6m 7.98%
Unlock
, the lowest is
$-15.6m 7.98%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-16.1m 17.41%
2024
$-15.6m 2.58%
Unlock
2025
$-4.5m 71.23%
Unlock
2026
$-4.1m 8.44%
Unlock

Net Margin

2023 -53,513.33%
2024
-11,010.70% 79.42%
Unlock
2025
-319.98% 97.09%
Unlock
2026
-201.87% 36.91%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -4.60 -4.48
17.41% 2.61%
P/E negative
EV/Sales 523.24

1 Analysts have issued a Zivo Bioscience Inc forecast for earnings per share. The average Zivo Bioscience Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-4.48
Unlock
. This is
8.01% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-4.48 8.01%
Unlock
, the lowest is
$-4.48 8.01%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-4.60 17.41%
2024
$-4.48 2.61%
Unlock
2025
$-1.29 71.21%
Unlock
2026
$-1.18 8.53%
Unlock

P/E ratio

Current -4.29 1,616.00%
2024
-4.66 8.62%
Unlock
2025
-16.19 247.42%
Unlock
2026
-17.70 9.33%
Unlock

Based on analysts' sales estimates for 2024, the Zivo Bioscience Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

523.24
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
521.69
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 928.75 670.75%
2024
523.24 43.66%
Unlock
2025
52.81 89.91%
Unlock
2026
36.42 31.03%
Unlock

P/S ratio

Current 926.00 674.90%
2024
521.69 43.66%
Unlock
2025
52.65 89.91%
Unlock
2026
36.31 31.03%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today